Immunological responses and clinical outcomes in pet dogs with osteosarcoma receiving standard of care therapy and a recombinant Listeria vaccine expressing HER2/neu
Nicola J. Mason,Laura E. Selmic,Audrey Ruple,Cheryl A. London,Lisa G. Barber,Kristen Weishaar,Julie Perry,J. Matthew Mahoney,Brian K. Flesner,Jeffrey N. Bryan,Jennifer L. Willcox,Jenna H. Burton,David M. Vail,William C. Kisseberth,Cheryl E. Balkman,Angela L. McCleary‐Wheeler,Kaitlin M. Curran,Haley Leeper,J. Paul Woods,Anthony J. Mutsaers